Published in J Clin Microbiol on February 01, 1993
Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev (2005) 2.24
Human herpesvirus 6. Clin Microbiol Rev (1997) 1.91
Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology (2003) 1.45
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med (2007) 1.32
Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study. Epilepsia (2012) 1.31
Identification of a lytic-phase origin of DNA replication in human herpesvirus 6B strain Z29. J Virol (1993) 1.23
Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol (2007) 1.14
Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol (1996) 1.14
Human herpes virus 6B: a possible role in epilepsy? Epilepsia (2008) 1.10
Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR. J Clin Microbiol (1994) 1.09
Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol (1996) 1.02
Presence of human herpesvirus 6 variants A and B in saliva and peripheral blood mononuclear cells of healthy adults. J Clin Microbiol (1996) 0.98
Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J Virol (1993) 0.95
Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J Clin Microbiol (1993) 0.95
Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay. PLoS One (2014) 0.92
Identification of human herpesvirus 6 latency-associated transcripts. J Virol (2002) 0.91
Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol (2009) 0.88
Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol (2001) 0.86
Divergent susceptibilities of human herpesvirus 6 variants to type I interferons. Proc Natl Acad Sci U S A (2010) 0.85
Detection of cervical infections in colposcopy clinic patients. J Clin Microbiol (2001) 0.85
Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames. J Virol (2000) 0.83
Germ-line transmitted, chromosomally integrated HHV-6 and classical Hodgkin lymphoma. PLoS One (2014) 0.81
No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Am J Transl Res (2012) 0.80
Impact of human herpes virus 6 in liver transplantation. World J Hepatol (2010) 0.77
Dominance of variant A in human herpesvirus 6 viraemia after renal transplantation. Virol J (2011) 0.76
Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol (1987) 58.68
Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med (1992) 3.42
Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology (1991) 2.37
Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30
Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol (1991) 2.16
Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia (1988) 1.18
Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants. Virology (1992) 1.17
Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes. J Virol Methods (1988) 0.99
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med (1983) 5.41
Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis (1975) 5.00
Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med (1982) 3.93
Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med (1986) 3.43
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.01
Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol (1988) 2.84
Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol (1985) (1986) 2.77
Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr (1976) 2.45
Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA (1985) 2.34
Low blood pressure and the risk of dementia in very old individuals. Neurology (2003) 2.30
Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30
18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys (1999) 2.27
Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies. Ann Intern Med (1978) 2.25
Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med (2000) 2.15
Rapid detection of respiratory syncytial virus with a monoclonal antibody. J Clin Microbiol (1983) 2.13
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13
Murine I-A beta chain polymorphism: nucleotide sequences of three allelic I-A beta genes. Science (1983) 2.04
Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr (1978) 2.01
Respiratory syncytial virus infections within families. N Engl J Med (1976) 1.99
Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis (1997) 1.98
Missed opportunities for childhood vaccinations in office practices and the effect on vaccination status. Pediatrics (1993) 1.97
Low-dose radiotherapy for stage I seminoma: early results. Radiother Oncol (1995) 1.95
Viral shedding patterns of children with influenza B infection. J Infect Dis (1979) 1.91
Possible transmission by fomites of respiratory syncytial virus. J Infect Dis (1980) 1.87
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86
Nosocomial respiratory syncytial virus infections. N Engl J Med (1975) 1.85
Modes of transmission of respiratory syncytial virus. J Pediatr (1981) 1.84
Neonatal respiratory syncytial virus infection. N Engl J Med (1979) 1.82
Children with influenza A infection: treatment with rimantadine. Pediatrics (1987) 1.80
Variable adherence of fimbriated Haemophilus influenzae type b to human cells. Infect Immun (1985) 1.77
Is underimmunization a marker for insufficient utilization of preventive and primary care? Arch Pediatr Adolesc Med (1995) 1.77
Immunization practices of pediatricians and family physicians in the United States. Pediatrics (1994) 1.75
Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr (1985) 1.73
Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr (1990) 1.64
White matter abnormalities in mobility-impaired older persons. Neurology (2000) 1.61
Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr (1990) 1.60
Evaluation of Simulated Presence: a personalized approach to enhance well-being in persons with Alzheimer's disease. J Am Geriatr Soc (1999) 1.59
Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen (1984) 1.56
Influenza surveillance in community-dwelling elderly compared with children. Arch Fam Med (1997) 1.55
Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52
Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J Neurovirol (1995) 1.52
Validation of dual x-ray absorptiometry for body-composition assessment of rats exposed to dietary stressors. Nutrition (2001) 1.52
Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis (1987) 1.51
Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun (1981) 1.50
Substantial between-hospital variation in outcome following first emergency admission for heart failure. Eur Heart J (2002) 1.47
Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics (1975) 1.46
Boost irradiation of breast carcinoma: teletherapy vs. brachytherapy. Eur J Obstet Gynecol Reprod Biol (2001) 1.40
A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study. Int J Radiat Oncol Biol Phys (2000) 1.37
Respiratory syncytial virus and influenza. Practical community surveillance. Am J Dis Child (1976) 1.36
Partner support and relapse in smoking-cessation programs. J Consult Clin Psychol (1983) 1.32
The association of apnea and respiratory syncytial virus infection in infants. J Pediatr (1982) 1.29
Effects of ribavirin on respiratory syncytial virus in vitro. Antimicrob Agents Chemother (1980) 1.28
Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis (1975) 1.28
Long-term prospective study in children after respiratory syncytial virus infection. J Pediatr (1984) 1.28
Clinical and physiological manifestations of bronchiolitis and pneumonia. Outcome of respiratory syncytial virus. Am J Dis Child (1979) 1.25
Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis (1994) 1.24
Lower respiratory tract illness in the first two years of life: epidemiologic patterns and costs in a suburban pediatric practice. Am J Public Health (1988) 1.20
Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells. J Virol (1991) 1.20
Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill. Ann Intern Med (1980) 1.20
Patients' vs nurses' assessments of postoperative pain and anxiety during patient- or nurse-controlled analgesia. Br J Anaesth (1999) 1.18
Ribavirin treatment of experimental respiratory syncytial viral infection. A controlled double-blind study in young adults. JAMA (1983) 1.18
Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants. Virology (1992) 1.17
The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA (1986) 1.16
Depression of established delayed hepersensitivity by mumps virus. J Immunol (1972) 1.16
Nosocomial respiratory syncytial viral infections. Should gowns and masks be used? Am J Dis Child (1981) 1.15
Identifying seizure clusters in patients with epilepsy. Neurology (2005) 1.14
Influenza in children with cancer. J Pediatr (1989) 1.14
Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics (1997) 1.14
Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Am J Clin Oncol (1999) 1.13
Control of nosocomial respiratory syncytial viral infections. Pediatrics (1978) 1.13
Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins. J Gen Virol (1989) 1.12
Evaluation of magnetic resonance cholangiography in the management of bile duct stones. Arch Surg (2000) 1.10
Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses. Infect Immun (1981) 1.09
A new method of diagnosing diaphragmatic injury using intraperitoneal technetium: case report. J Trauma (1992) 1.07
Progressive development of diffuse liver hemangiomatosis. J Hepatol (1999) 1.07
Incidence of recall, nightmares, and hallucinations during analgosedation in intensive care. Intensive Care Med (2001) 1.06
Mycoplasma pneumoniae infection associated with migratory polyarthritis. Am J Dis Child (1974) 1.06
Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys (2000) 1.05
Parainfluenza viral infections in children: correlation of shedding with clinical manifestations. J Pediatr (1977) 1.04
X-ray structure analysis of the iron-dependent superoxide dismutase from Mycobacterium tuberculosis at 2.0 Angstroms resolution reveals novel dimer-dimer interactions. J Mol Biol (1995) 1.04
Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J Pediatr (1998) 1.03
Constraints on general slowing: a meta-analysis using hierarchical linear models with random coefficients. Psychol Aging (1998) 1.03
Nosocomial viral infections: I. Epidemiology and significance. Infect Control (1982) 1.02
The Saccharomyces cerevisiae MUM2 gene interacts with the DNA replication machinery and is required for meiotic levels of double strand breaks. Genetics (2001) 1.02
Epidemiology and laboratory diagnosis of infection with viral and bacterial pathogens in infants hospitalized for suspected sepsis. J Pediatr (1989) 1.02
Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80). AIDS (1996) 1.01
Ribavirin: beginning the blitz on respiratory viruses? Pediatr Infect Dis (1986) 1.01
Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics (1999) 1.00
Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys (1996) 1.00
Human herpesvirus 6B origin: sequence diversity, requirement for two binding sites for origin-binding protein, and enhanced replication from origin multimers. J Virol (1994) 1.00